Tagged with " 3D Bioprinting"

VIVIO – 3D-Druck von Hautzellen

3D-Druck von Hautzellen – Das visionäre Projekt „Vivio“ ist eine medizinische Produktkonzeption, die sich mit der Behandlung von Erkrankungen und Beschädigungen der Haut beschäftigt.

In der letzten Zeit wurde das Thema Haut- und Organdruck immer mehr publik. Da ich dieses Themengebiet sehr interessant fand, habe ich mich intensiver damit beschäftigt. Dabei konnte ich feststellen, dass bis jetzt kein Designkonzept dafür existiert, um diese innovative Technologie verständlich für Ärzte, potentielle Patienten und alle Interessierten darzustellen.
(…weiter auf jamesdysonaward.org)

Design Student Creates 3D Skin Printer Concept to Alleviate Burns & Skin Disease

Many of us completely take our skin–generally quite durable–for granted, punishing it under the glare of the sun, caking it with makeup, and subjecting it to a wide array of materials and chemicals, generally without a thought. For some though, skin disease and trauma make life itchy, embarrassing, and, in the case of burn victims, devastatingly painful–and they can be potentially life threatening.
(…weiter auf 3dprint.com)

Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information

SAN DIEGO, April 21, 2015 /PRNewswire/ — Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced preliminary financial information (unaudited) for the fourth quarter and fiscal year ended March 31, 2015.

Based on preliminary financial information for the fiscal quarter and year-ended March 31, 2015, Organovo estimates:

– Total net revenues of approximately $268 thousand for the quarter, and approximately $571 thousand for the fiscal year
– Total net cash utilization during fiscal 2015 fourth quarter and fiscal year ended March 31, 2015 of approximately $6.3 million and $21.1 million, respectively; and
– The Company closed the year with cash and cash equivalents of approximately $50.1 million
(…weiter auf organovo.com)

Watch As Researchers Create Beating, 3D Printed Heart Organoid

They call them “organoids,” and they’re 3D printed, beating cardiac cells which are sure to inspire scientists and biologists while raising ethical concerns among critics intent on stopping the progress of the technology.

The groundbreaking research program aimed at creating human organs is the result of a project at the Wake Forest Baptist Medical Center Institute for Regenerative Medicine, and it features heart cells which are made functional and shaped using a highly-specialized 3D printer.
(…weiter auf 3dprint.com)

Hungry? 3D printer can print out a steak

Rockefeller heir invests in firm taking 3D printing to dinner table by growing animal tissue.

An heir of one of the world’s richest families is banking on 3D „printing“ of meat as the next big industry of the future.

Justin Rockefeller, a great-great-grandson of Standard Oil founder John D. Rockefeller, is „a relatively small investor“ in New York-based Modern Meadow, which has created a „steak chip“ by growing animal tissues in a laboratory and then using a 3D printer to build up layers of meat into the size of a potato chip.
(…weiter auf nzherald.co.nz)

Bioprinting Solutions & Dreams: an Interview with 3D Bio’s Dr. Vladimir Mironov

This was may day so far: I wrote about an amazing new development in the adoption of 3D printing for surgery in Italy, an incredible new 3D printing technology developed by a graduate student in Buffalo, and a stunning “smart doll” created by a self-described gaijin (non-Japanese person) in Japan. Only a couple of years ago, this would be science fiction. Instead, to top it off, here I am enjoying the sunset with a Campari Spritz, writing about my interview with Vladimir Mironov, the scientist behind most of the work at Russia’s 3D Bioprinting Solutions (3D Bio for short).
(…weiter auf 3dprintingindustry.com)


(Quelle: Youtube)

Russian Researchers Say 3D Printing with Animal Bone May Regenerate Human Bones, Manage Pain

Some of us have had the experience ourselves, regretfully, of enduring a trauma resulting in a broken limb which never completely healed. More often, we know others who have been through falls, motorcycle accidents, car wrecks, etc., and while they seemed to get through the healing process, many years later they still have an exaggerated or maybe slight limp—and may even be somewhat or completely debilitated. While it’s heartbreaking enough to see an adult have permanent damage due to bone trauma, it’s doubly so to see such a thing in a child before they have even begun to live fully.
(…weiter auf 3dprint.com)

Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue

SAN DIEGO, April 1, 2015 /PRNewswire/ — Organovo Holdings, Inc. (NYSE MKT: ONVO) („Organovo“), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, presented data on the company’s in vitro three-dimensional kidney tissue at the 2015 Experimental Biology conference in Boston, Massachusetts.

„Kidney represents an ideal extension of Organovo’s capabilities to 3D bioprint organ tissues that can be tremendously useful in pharmaceutical research,“ said Keith Murphy, Chairman and Chief Executive Officer at Organovo. „The results released today admirably demonstrate a proof of concept that kidney is on the way to becoming another core commercial tissue for Organovo. The product that we intend to build from these initial results can be an excellent expansion for our core customers in toxicology, who regularly express to us an interest in having better solutions for the assessment of human kidney toxicity.“

For the first time, fully human kidney proximal tubular tissues have been generated that are three-dimensional, and consist of multiple tissue-relevant cell types arranged to recapitulate the renal tubular / interstitial interface. The tissues are fabricated using Organovo’s proprietary NovoGenTM bioprinting platform, and will ultimately join the company’s exVive3DTM Liver tissues to expand the repertoire of physiologically-relevant tissue systems available for toxicity and efficacy testing as well as disease modeling. Dr. Sharon Presnell, Chief Technology Officer and Executive Vice President of Research and Development, stated, „Our bioprinted human kidney tissue represents a significant technical advance over the simple monolayer cell line cultures that predominate today. The histologic and functional features of the initial prototypes are compelling, and the in vitro durability of the system will likely enable the assessment of drug effects at chronic, physiologically relevant doses. Furthermore, the cellular complexity of the system will likely support mechanistic investigations into drug responses, including end points that have been difficult or impossible to assess in vitro, including tubular fibrosis and post-injury recovery.“

Key findings and attributes from Organovo’s research include:
(…weiter auf organovo.com)

Seiten:«12345678...30»

Wir setzen für unseren Internetauftritt sog. Cookies ein. Durch Einstellungen in Ihrem Browser können Sie die weitere Verwendung von Cookies deaktivieren. Weitere Informationen zu Cookies finden Sie in unserer Datenschutzerklärung

Die Cookie-Einstellungen auf dieser Website sind auf "Cookies zulassen" eingestellt, um das beste Surferlebnis zu ermöglichen. Wenn du diese Website ohne Änderung der Cookie-Einstellungen verwendest oder auf "Akzeptieren" klickst, erklärst du sich damit einverstanden.

Schließen